Campbell Newman Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.96M Buy
37,774
+1,644
+5% +$112K 0.22% 50
2026
Q1
$2.34M Buy
36,130
+603
+2% +$42.5K 0.19% 55
2025
Q4
$2.39M Sell
35,527
-1,351
-4% -$90.9K 0.18% 56
2025
Q3
$2.7M Buy
36,878
+153
+0.4% +$10.2K 0.2% 57
2025
Q2
$1.91M Buy
36,725
+2,439
+7% +$139K 0.15% 70
2025
Q1
$2.19M Sell
34,286
-87
-0.3% -$5.05K 0.19% 57
2024
Q4
$1.64M Sell
34,373
-185
-0.5% -$9.49K 0.13% 74
2024
Q3
$1.98M Sell
34,558
-569
-2% -$32.6K 0.15% 66
2024
Q2
$1.84M Buy
35,127
+84
+0.2% +$3.68K 0.15% 63
2024
Q1
$1.43M Buy
35,043
+1,489
+4% +$55.8K 0.12% 79
2023
Q4
$1.24M Sell
33,554
-507
-1% -$19.1K 0.11% 81
2023
Q3
$1.3M Sell
34,061
-595
-2% -$24.4K 0.12% 77
2023
Q2
$1.25M Buy
34,656
+768
+2% +$26.2K 0.11% 75
2023
Q1
$1.29M Buy
+33,888
New +$1.59M 0.13% 73

Other funds holding HALO

Campbell Newman Asset Management's HALO Position: Q2 2026 in Review

Campbell Newman Asset Management increased its Halozyme (HALO) stake by 4.6% in Q2 2026, buying an estimated $112K and bringing the position to 37,774 shares worth $2.96M. The position accounts for 0.22% of the portfolio, ranked #50.

Campbell Newman Asset Management first reported a position in HALO in Q1 2023 and has held it in 14 quarters since. 236 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Campbell Newman Asset Management held 37,774 shares of Halozyme worth $2.96M as of Q2 2026.
  • Campbell Newman Asset Management bought 1,644 Halozyme shares in Q2 2026, an estimated $112K.
  • Halozyme made up 0.22% of Campbell Newman Asset Management's portfolio in Q2 2026, its #50 holding.
  • Campbell Newman Asset Management first reported a position in Halozyme in Q1 2023 and has held it in 14 quarters since.
  • 236 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Campbell Newman Asset Management's 13F filing for Q2 2026, filed 21 Jul 2026.